Health Care & Life Sciences » Biotechnology | ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
20,644.00
23,010.00
24,534.00
16,392.00
39,115.00
47,374
Cost of Goods Sold (COGS) incl. D&A
6,594.00
7,015.00
8,219.00
6,758.00
10,149.00
Gross Income
14,050.00
15,995.00
16,315.00
9,634.00
28,966.00
SG&A Expense
28,101.00
49,540.00
68,145.00
117,555.00
152,965.00
EBIT
14,051.00
33,545.00
51,830.00
107,921.00
123,999.00
Unusual Expense
2,893.00
19,476.00
11,050.00
5,684.00
5,104.00
Non Operating Income/Expense
592.00
14,914.00
2,490.00
423.00
726.00
Interest Expense
1,848.00
3,070.00
3,228.00
4,890.00
8,278.00
Pretax Income
18,158.00
1,915.00
63,244.00
118,555.00
136,342.00
Income Tax
829.00
4,491.00
6,459.00
7,886.00
16,306.00
Equity in Affiliates
69.00
-
-
-
-
Consolidated Net Income
17,398.00
2,576.00
56,785.00
110,669.00
120,036.00
Net Income
16,489.00
5,939.00
50,961.00
100,807.00
109,731.00
Net Income After Extraordinaries
16,489.00
5,939.00
50,961.00
100,807.00
109,731.00
Net Income Available to Common
16,489.00
5,939.00
50,961.00
100,807.00
109,731.00
EPS (Basic)
0.03
0.01
0.09
0.17
0.16
Basic Shares Outstanding
493,236.00
530,422.20
570,848.90
598,393.00
683,954.00
EPS (Diluted)
0.03
0.01
0.09
0.17
0.16
Diluted Shares Outstanding
493,236.00
578,095.60
570,848.90
598,393.00
683,954.00
EBITDA
13,182.00
31,851.00
49,393.00
104,671.00
119,423.00
Non-Operating Interest Income
42.00
310.00
374.00
363.00
313.00
Minority Interest Expense
909.00
3,363.00
5,824.00
9,862.00
10,305.00

About ProMetic Life Sciences

View Profile
Address
440 Armand-Frappier Boulevard
Laval Québec H7V 4B4
Canada
Employees -
Website http://www.prometic.com
Updated 07/04/2019
Prometic Life Sciences, Inc. engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation, and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment is involved in large-scale purification of biologics and the elimination of pathogens.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.